首页> 美国卫生研究院文献>Cardiovascular Endocrinology >Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities
【2h】

Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities

机译:糖尿病患者的预防与管理心血管疾病:当前挑战与机遇

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

More than 100 million people in the USA have diabetes or prediabetes and are at high risk for developing cardiovascular disease. Current evidence-based guidelines support a multifactorial approach in patients with diabetes, including lifestyle intervention and pharmacological treatment of hyperglycemia, hypertension, and dyslipidemia. In addition, recent cardiovascular outcome trials demonstrated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists improve cardiovascular outcomes in patients with diabetes. Albeit this evidence, over 80% of patients with diabetes do not achieve the recommended treatment goals. Considering the rising burden of cardiovascular complications, there is need to improve the quality of care in patients with diabetes. In this review, we discuss the current quality of health care in patients with diabetes in the USA, identify barriers to achieve guideline-recommended treatment goals and outline opportunities for the improvement in caring for patients with diabetes.
机译:美国超过1亿人患有糖尿病或前驱糖尿病,并且患心血管疾病的风险很高。目前的基于循证指南支持糖尿病患者的多因素方法,包括高血糖,高血压和血脂血症的生活方式干预和药理治疗。此外,最近的心血管成果试验证明钠 - 葡萄糖COT转换器-2抑制剂和胰高血糖素样肽1受体激动剂改善糖尿病患者的心血管结果。虽然这一证据,超过80%的糖尿病患者没有达到推荐的治疗目标。考虑到心血管并发症的负担上升,需要提高糖尿病患者的护理质量。在这篇综述中,我们讨论了美国糖尿病患者的当前医疗保健质量,确定了实现指南推荐的治疗目标和概述糖尿病患者关心的概述机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号